触媒性銅鉄ナノ粒子によって引き起こされる細胞死メカニズムを解明する

Miguel Encinas-Gimenez^1,2,3, Ana Martín-Pardillos^1,2,4, Javier Bonet-Aleta^1,2

¹Institute of Nanoscience and Materials of Aragon (INMA), CSIC-Universidad de Zaragoza, Campus Río Ebro, Edificio I+D, C/Poeta Mariano Esquillor, s/n, 50018, Zaragoza, Spain.

Nanoscale

|September 5, 2025

まとめ

銅鉄ナノ粒子はガン細胞のグルタチオン (GSH) を枯渇させ,細胞死を引き起こし,腫瘍の成長を減少させます. このナノ医療アプローチは選択的な癌治療のために腫瘍の微小環境をターゲットにしています

科学分野:

ナノ医療
バイオマテリアル科学
癌生物学

背景:

ナノ医療は,腫瘍の微小環境 (TME) をターゲットにすることで,先進的な抗がん装置を提供しています.
触媒ナノ材料 (ナノ触媒) は,腫瘍細胞における過剰発現した代謝産物を標的として選択的ながん治療に有望である.
グルタチオン (GSH) は,多くの癌で過剰発現する重要な抗酸化物質であり,潜在的な治療目標です.

研究の目的:

メソ-2,3-ジマーカプトスカルシン酸でコーティングされた新しい銅と鉄ベースのナノ粒子 (CuFe@DMSA NPs) のメカニズムを調査する.
ガン細胞におけるGSHの減少と活性酸素種 (ROS) の誘発におけるCuFe@DMSANPの有効性を評価する.
CuFe@DMSA NPsの抗がん効果を in vitro と in vivo で確認する.

主な方法:

CuFe@DMSA NPの合成と特徴づけ
GSHの減少,ROSの生成,細胞周期停止,アポトーシス,およびフェロプトーシスのような細胞死を評価するために,がん細胞系に関するインビトロ研究.
腫瘍の成長抑制とアポトーシスの誘導を評価するためにマウスでのin vivo研究.

主要な成果:

CuFe@DMSA NPsは,細胞内GSHを効果的に枯渇させ,がん細胞でROSを生成する.
ナノマテリアルはフェロプトーシスのような細胞死,細胞循環停止,腫瘍細胞のアポプトーシスを誘発する.
CuFe@DMSA NPを vivoで投与すると,アポトーシスを増加させることで,腫瘍の成長が著しく減少します.

結論:

CuFe@DMSA NPsは,TMEにおけるGSHを選択的に標的にすることで,がん治療のための有望なナノ医療戦略を表しています.
これらのナノ粒子によるフェロプトーシスのような細胞死とアポトーシスの誘導は,新しい治療方法を提供します.
CuFe@DMSA NPsに関するさらなる研究は,より効果的で標的型のがん治療につながる可能性があります.

さらに関連する動画

07:42

Activation of Apoptosis by Cytoplasmic Microinjection of Cytochrome c

Published on: June 29, 2011

17.5K

07:01

A New Portable In Vitro Exposure Cassette for Aerosol Sampling

Published on: February 22, 2019

7.2K

関連する概念動画

01:30

Overview of Cell Death

7.7K

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...

7.7K

01:16

Necrosis

4.8K

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...

4.8K

01:46

Electron Transport Chain: Complex I and II

15.0K

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

15.0K

01:18

Autophagic Cell Death

3.5K

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...

3.5K

01:31

The Intrinsic Apoptotic Pathway

6.8K

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...

6.8K

01:17

The Extrinsic Apoptotic Pathway

6.6K

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...